1. Tobramycin, amikacin, sissomicin, and gentamicin resistant Gram-negative rods;Drasar, F.A.; Farrell, W.; Maskell, J.; Williams, J.D.;British Medical Journal,1976
2. Strains of Pseudomonas putrefaciens from clinical material;Holmes, B.; Lapage, S.P.; Malnick, H.;Journal of Clinical Pathology,1975
3. Revised description, from clinical isolates, of Flavobacterium odoratum Stutzer and Kwaschnina 1929, and designation of the neotype strain;Holmes, B.; Snell, J.J.S.; Lapage, S.P.;International Journal of Systematic Bacteriology,1977
4. Revised description, from clinical strains, of Flavobacterium breve;Holmes, B.; Snell, J.J.S.; Lapage, S.P.;(Lustig) Bergey et al; and proposal of the neotype strain,1978
5. Comparison of group IIf with Flavobacterium and Moraxella;Owen, R.J.; Snell, J.J.S.;Antonie van Leeuwenhoek Journal ofMicrobiology and Serology,1973